Durable complete radiographic and biochemical response to olaparib in BRCA2-mutated metastatic castration-resistant prostate cancer: a long-term responder case

Key Points

• Durable biochemical and radiographic responses were observed over an extended follow-up period.
• Significant long-term effects of olaparib treatment were highlighted in a patient with BRCA2 mutation.
• Observational analysis of a long-term responder reveals important insights into treatment efficacy.
• Success in this case suggests potential for further exploration in similar metastatic cancer scenarios.